The global Microbial Coagulants market is expected to reach a market valuation of US$ 224 million by 2023, recording a CAGR of 3.4% from 2023 to 2033.
Microbial coagulants are enzymes used in the cheese-making process to coagulate milk. These microorganisms include bacteria, fungus, and yeast. These enzymes are frequently referred to as rennet replacements or rennet. Casein, a milk protein, is broken down by microbial coagulants, causing curds to form. The texture, flavor, and ripening period of the cheese produced can all be impacted by the kind of microbial coagulant utilized. Microbial coagulants, an alternative to conventional animal rennet, are typically regarded as safe and effective. They are commonly employed in the dairy sector to increase cheese yields and uniformity as well as in the manufacturing of vegetarian and vegan cheeses.
| Microbial Coagulants Market Size (2023E) | US$ 224 million |
| Microbial Coagulants Market Projected Size (2033F) | US$ 314 million |
| Value CAGR (2023 to 2033) | 3.4% |
| Top 3 Countries Marketing Share | 63.5% |
The Rhizomucor miehei, a fermentation-produced chymosin from either fungi or yeast, is the typical source of microbial coagulants. They are an organic, non-GMO, non-animal product that has received certification for both Kosher and halal by reputable certifying organizations across many different areas and nations. Rhizomucor miehei or pusillus, which are mostly utilized in the food sector for the manufacturing of cheese, are fermented under regulated conditions to create the microbial coagulants.
In our new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights into key factors driving demand for Microbial Coagulants.
| Market Statistics | Details |
| Jan–Jun (H1), 2021 (A) | 3.1% |
| Jul–Dec (H2), 2021 (A) | 3.2% |
| Jan–Jun (H1),2022 Projected (P) | 3.3% |
| Jan–Jun (H1),2022 Outlook (O) | 3.4% |
| Jul–Dec (H2), 2022 Projected (P) | 3.2% |
| Jul–Dec (H2), 2022 Outlook (O) | 3.3% |
| Jan–Jun (H1), 2023 Projected (P) | 3.5% |
With the introduction of specialized microbe strains for cheese-making and the commercialization of fermentation technologies, the usage of microbial coagulants increased in the middle of the 20th century. Growing interest in microbial coagulants as an alternative to animal rennet has resulted from a rise in the demand for products that are plant-based and animal-free in recent years. Additionally, research is being done on novel microbial coagulants with enhanced functionality and specificity. The need for microbial coagulants is expected to continue growing in the future, and research and development efforts are being made to increase their functionality and specificity.
Manufacturers of cheese encounter a variety of difficulties, including demands for high quality, flavor, texture, and sliceability, as well as pressure to maximize whey value. The requirement to produce cheese in an efficient, sustainable, and environmentally friendly manner is another barrier for producers. Microbial coagulants provide the best option for satisfying these needs. Calf rennet, which comes from the stomachs of ruminants, is chosen over microbial coagulants due to rising concerns about animal welfare. The market for microbial coagulants is anticipated to rise as more people switch to vegetarian diets as a result of the product's non-animal origin.
Milk Protein Market:
| Attributes | Milk Protein Market |
| CAGR (2023 to 2033) | 5% |
| Market Value (2023) | US$ 11,856 million |
| Growth Factor | Milk also contains all nine essential amino acids and 3.3 percent protein. Despite the fact that milk protein is produced naturally in the mammary gland, research indicates that 60% of the proteins required to create amino acids can be found in cow milk. |
| Key Trend | In terms of revenue, the milk protein market is anticipated to have a positive growth outlook, as are the milk protein isolate type, powdered form, and infant formula industry. |
Dairy Ingredients Market:
| Attributes | Dairy Ingredients Market |
| CAGR (2023 to 2033) | 4% |
| Market Value (2023) | US$ 62,400 million |
| Growth Factor | Due to the presence of protein and the use of dairy ingredients in cosmetics, the consumption of ready-to-eat foods like cheese and other functional food ingredients has increased. |
| Key Trend | Due to rising demand for functional ingredients and global trends toward healthier diets, the market for dairy ingredients is expanding. |
Due to the rising demand for plant-based and animal-free goods, particularly in the dairy industry, the North American market for microbial coagulants has been expanding rapidly in recent years. North America's largest market for microbial coagulants is the United States, which is also where most of the demand is found. The strong demand for vegetarian and vegan dairy products as well as growing public awareness of the negative environmental effects of animal agriculture are to blame for this. The presence of significant cheese producers and suppliers in the area has also increased the demand for microbial coagulants.
The regulatory framework of the European Union encourages the use of microbial coagulants in the production of cheese, making it simpler for producers to utilize these substitutes. Further promoting the use of microbial coagulants, the EU also established a legal definition for vegetarian and vegan cheese products. The demand for plant-based and animal-free cheese products, improvements in microbial fermentation technologies, and ongoing research and development projects aimed at enhancing the functionality and specificity of microbial coagulants are all expected to contribute to the continued growth of the European market for microbial coagulants in the years to come.
Microbial coagulants are also widely employed in the dairy industry, where they increase cheese production and uniformity. Other dairy products like yogurt and sour cream are also produced using microbial coagulants. The market for microbial coagulants is expanding as a result of the rising demand for vegetarian and vegan products. These substitutes are used to create plant-based and animal-free dairy products by taking the place of rennet made from animal products while manufacturing cheese.
In the pharmaceutical and biotechnology sectors, microbial coagulants may potentially find use. These industries use microbial coagulants to create enzymes and other biologically active substances that are used in a variety of processes, such as the discovery and production of drugs. The creation of enzymes, which are physiologically active molecules that catalyze chemical reactions in the body, also uses microbial coagulants.
In the pharmaceutical and biotechnology fields, enzymes are used in a broad variety of processes, such as biocatalysis, diagnostics, and the discovery of new drugs. Proteases, lipases, and amylases are just a few of the many enzymes that can be produced with microbial coagulants.
The Microbial Coagulants market is only slightly fragmented. The major market players are concentrating on expansion tactics like mergers and acquisitions and extending their distribution networks to increase their market position. The manufacturers in the market used a variety of competitive methods, including product releases, free-from claims, and organic and natural origin claims.
| Attribute | Details |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ million for Value and Metric Ton for Volume |
| Key Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa |
| Key Countries Covered | United States of America, Canada, Brazil, Mexico, Germany, United Kingdom, France, Italy, Spain, Nordic, Russia, Poland, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Singapore, Australia, New Zealand, GCC countries, North Africa, South Africa, others. |
| Key Segments Covered | Form, Source, End Use, Distribution Channel, and Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The Microbial Coagulants Market is valued at US$ 224 million for 2023.
The Microbial Coagulants Market valuation is expected to be US$ 314 million in the year 2023.
The value of CAGR for the Microbial Coagulants Market is estimated to be 3.4%.
The cheese industry would garner a significant market value share by 2023.
Explore Similar Insights
Microbial Coagulants Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
